The Cardiac Bioelectricity and Arrhythmia Center (CBAC) is an interdisciplinary center whose goals are to study heart rhythms and their disorders (cardiac arrhythmias), and to develop new tools for their diagnosis and treatment in the prevention of disabilities and cardiac death.


The CardioInsight ECGI system was cleared by the FDA. After 30 years of development and validation in CBAC Director Yoram Rudy's laboratory, he hopes to see ECGI in clinical use in hospitals, helping to treat cardiac patients.



Jeanne NerbonneMarch 6, 2017 - Peter J. Mohler, Ph.D., The Ohio State University

March 20, 2017 - Saman Nazarian, M.D., Ph.D., The University of Pennsylvania Perelman School of Medicine

April 17, 2017 - Emilia Entcheva, Ph.D., The George Washington University

May 8, 2017 - Marc A. Vos, Ph.D., Utrecht University, The Netherlands

January 18, 2017 - Andrew D. McCulloch, Ph.D., University of California San Diego

January 23, 2017 - Amit Noheria, M.B.B.S. (M.D.), S.M., Washington University in St. Louis School of Medicine

February 3, 2017 - Blanca Rodriguez, Ph.D., University of Oxford, United Kingdom


Peter J. Mohler

Monday, March 6, 2017
Whitaker Hall, Room 218, Danforth Campus
4:30PM - 5:30PM

Peter J. Mohler, Ph.D.

“Defining New Pathways Underlying Human Arrhythmia"

Professor & Director
The Dorothy M. Davis Heart & Lung Research Institute
Chair & Professor, Physiology & Cell Biology
Associate Dean, Basic Sciences
The Ohio State University

More Information

Copyright ©2005-2014 CBAC. All rights reserved.